Position history for Assenagon Asset Management S.A.'s holdings in BRIDGEBIO PHARMA INC
Assenagon Asset Management S.A. holds 44,092 shares of BBIO (BRIDGEBIO PHARMA INC), worth $3.3M as of 2026-Q1. The position was increased (+31.6% shares). BBIO represents 0.0% of Assenagon Asset Management S.A.'s portfolio.
Current Value
$3.3M
Current Shares
44,092
Total Value Change
-$3M
Total Shares Change
-202,803
Other major holders of BBIO: VIKING GLOBAL INVESTORS LP, VANGUARD GROUP INC
Increased |
| 44,092 |
+31.6% |
| $3.3M |
| 0.0% |
| $64.53 |
34 |
| 2025-Q4 | Decreased | 33,513 | -87.1% | $2.6M | 0.0% | $75.48 | 0 |
| 2025-Q3 | Decreased | 258,904 | -26.1% | $13.4M | 0.0% | $51.96 | 0 |
| 2025-Q2 | Decreased | 350,411 | -68.7% | $15.1M | 0.0% | $44.86 | 0 |
| 2025-Q1 | Increased | 1.1M | +4544.6% | $38.8M | 0.1% | $35.11 | 47 |
| 2024-Q4 | Unchanged | 24,134 | 0.0% | $662,237 | 0.0% | $27.32 | 0 |
| 2024-Q3 | Decreased | 24,134 | -90.2% | $614,452 | 0.0% | $24.94 | 0 |
| 2024-Q2 | Increased | 246,895 | +3429.6% | $6.3M | 0.0% | $25.33 | 44 |